Changeflow GovPing Healthcare Proposed Federal Workplace Drug Testing Guidelines
Priority review Consultation Added Draft

Proposed Federal Workplace Drug Testing Guidelines

Email

Summary

The Substance Abuse and Mental Health Services Administration (SAMHSA) has issued a proposed rule to update federal workplace drug testing guidelines. This consultation seeks public comment on the proposed changes to these guidelines.

What changed

SAMHSA has published a proposed rule to revise its guidelines for federal workplace drug testing programs. The proposal outlines potential updates to testing methodologies, laboratory procedures, and the types of substances that may be tested for. This action is a significant step towards modernizing federal drug-free workplace standards and ensuring the integrity of testing processes across federal agencies.

Regulated entities, particularly federal agencies and their contractors, should review the proposed changes and consider submitting comments. The comment period deadline is crucial for influencing the final rule. Failure to comply with updated guidelines once finalized could lead to non-compliance findings and potential sanctions, although specific penalties are not detailed in this proposal.

What to do next

  1. Review proposed changes to federal workplace drug testing guidelines
  2. Submit comments to SAMHSA by the specified deadline

Source document (simplified)

Content

Download File

Download

Classification

Agency
SAMHSA
Instrument
Consultation
Legal weight
Non-binding
Stage
Draft
Change scope
Substantive

Who this affects

Applies to
Employers
Geographic scope
National (US)

Taxonomy

Primary area
Employment & Labor
Operational domain
Compliance
Topics
Public Health Occupational Safety

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Substance Abuse and Mental Health Services Administration publishes new changes.

Free. Unsubscribe anytime.